PLMA_1170x120_5-28-21

Roxane Laboratories

Hikma to buy Roxane for $2.65 billion

Hikma to buy Roxane for $2.65 billion

LONDON — Hikma Pharmaceuticals PLC, a fast growing multinational pharmaceutical group, plans to acquire Roxane Laboratories from Boehringer Ingelheim in a deal valued at $2.65 billion. Hikma said the agreement stands to transform its position in the U.S. generic drug market, establishing the company as the sixth-largest generics maker by revenue. The addition of Roxane

Roxane rolls out Lotronex generic

COLUMBUS, Ohio — Roxane Laboratories Inc. has released alosetron hydrochloride tablets, a treatement for irritable bowel syndrome in women. The company said the tablets, available in 0.5-mg and 1-mg strengths in 30-count bottles, has begun shipping to wholesalers and pharmacies nationwide. According to Roxane, the Food and Drug Administration approved the Abbreviated New Drug Application